Fig. 1From: Upfront radical surgery with total mesorectal excision followed by adjuvant FOLFOX chemotherapy for locally advanced rectal cancer (TME-FOLFOX): an open-label, multicenter, phase II randomized controlled trialFlow diagram of the trial. DFS disease-free survival, OS overall survival, TME total mesorectal excision, CRT chemoradiotherapy, mFOLFOX modified FOLFOX, folinic acid (or leucovorin), 5-fluorouracil, and oxaliplatin Back to article page